A pro-inflammatory profile of endothelial cell in Lonomia obliqua envenomation.
Lonomia obliqua envenomation is characterized by intense local inflammatory reaction, which, dependent on the severity of the case, is followed by severe clinical manifestations related to hemorrhagic disorders that can lead to fatal outcome. These effects were imputed to several toxins present in L. obliqua venom, which are responsible for procoagulant, anticoagulant as well as antithrombotic activities, being also able to interfere with vascular cells functions. In this work, the intravital microscopy analysis show that after administration of low doses of L. obliqua venom (1-3 μg/ml) on hamster cheek pouch, there was no alterations neither on arterioles or venules caliber nor in the vascular permeability up to 30 min. However, after 10 min in contact with venom occurred a clear activation in the vascular bed, characterized by an increase in leukocyte rolling and adhesion on endothelium of hamster cheek pouch venules. A confocal analysis of vascular beds, confirmed these results showing an increase in endothelial E-selectin and VCAM-1 expression. The effects of L. obliqua venom on human endothelial cell (EC) in vitro were also investigated. The treatment of EC with venom (1-3 μg/ml) did not affect cell viability. However, at concentrations as low as 3 μg/ml of L. obliqua venom modifies actin cytoskeleton dynamics, and increases focal adhesion contacts, inducing stress fiber formation, focal adhesion kinase (FAK) phosphorylation and its subsequent association to actin. These effects are followed by the activation of NF-κB pathway, a critical signaling in several events associated to vascular inflammation. Accordingly, L. obliqua venom leads to a significant increase in COX-2, NOS-2, HO-1, MMP-2 and MMP-9 expression. Taken together the data show that, even at low concentrations, L. obliqua venom can activate endothelial cells, which assume a pro-inflammatory profile, contributing for local effects and probably also for systemic disturbances due to its ability to modulate the properties of the vascular system.
Laboratory of Biochemistry and Cellular Pharmacology, IBRAG, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
Vany
V
Nascimento-Silva
Genilson
G
Rodrigues da Silva
João Alfredo
JA
Moraes
Fátima Z
FZ
Cyrino
Sérgio H
SH
Seabra
Eliete
E
Bouskela
Jorge
J
Almeida Guimarães
Christina
C
Barja-Fidalgo
D000818:Animals; D015153:Blotting, Western; D006224:Cricetinae; D019040:E-Selectin / Q000378:metabolism; D042783:Endothelial Cells / Q000166:cytology / Q000201:enzymology / Q000378:metabolism*; D004798:Enzymes / Q000378:metabolism; D047468:Immunoprecipitation; D007249:Inflammation / Q000139:chemically induced*; D007915:Lepidoptera; D010766:Phosphorylation; D019010:Vascular Cell Adhesion Molecule-1 / Q000378:metabolism; D014688:Venoms / Q000633:toxicity*
D019040:E-Selectin; D004798:Enzymes; D019010:Vascular Cell Adhesion Molecule-1; D014688:Venoms